Novadip Biosciences SA announces first pediatric patient with congenital pseudoarthrosis of the tibia undergoes implantation with NVD-003, an autologous tissue regeneration product, in Phase 1b/2a US/EU clinical trial Trellis Bioscience announces positive interim Phase 1 results for TRL1068, a novel native human monoclonal antibody which reduces bacterial biofilm burden in chronic prosthetic joint infections Paragraf acquires Cardea Bio to extend graphene electronics leadership VUV Analytics announces $20 million financing ProterixBio announces commercial offering of Quantitative Soluble ST2 Assay Picocom and Antevia Networks collaborate to provide new innovative 5G in-building solutions for enterprise private networksBack To News
January 31, 2018
Happy New Year to our extended Bright
The new year is here and we want to share a couple of the exciting changes at BrightVolt from 2017. We will continue to hire and expand our capabilities in 2018 and deliver on our mission of providing the world’s thinnest, safest, most flexible thin film batteries and solutions!